← FDA DRUG APPROVALS

FDA ANDA · ANDA073638

PIROXICAM

Sponsor: TEVA

APPLICATION
ANDA073638
TYPE
ANDA
ORIGINAL APPROVAL
1994-01-28
LATEST ACTION
1999-04-09
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

PIROXICAMDiscontinued
PIROXICAM 20MG · CAPSULE · ORAL

Approval history

1999-04-09Manufacturing (CMC) · Supplement 2AP
1998-03-17Manufacturing (CMC) · Supplement 4AP
1997-10-07Manufacturing (CMC) · Supplement 3AP
1996-07-26Manufacturing (CMC) · Supplement 1AP
1994-01-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →